Vaccines Global Market Opportunities And Strategies To 2031

Name: Vaccines Global Market Opportunities And Strategies To 2031
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Download Sample Buy Report

Vaccines Market Opportunities And Strategies To 2032

Vaccines Market 2023 – By Type (Anti-Infective Vaccines, Anti-Cancer Vaccines, Other Type), By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Technologies), By Route Of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Other Route of Administration), By Valance (Monovalent, Multivalent), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales), And By Region, Opportunities And Strategies – Global Forecast To 2032

Vaccines Global Market Opportunities And Strategies To 2031

Report Price : $5000.00 $3500.00 | Pages : 343 | Published : January 2023 | Delivery Time: Immediately Info | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Vaccines Global Market Opportunities And Strategies To 2032

Proud Members Of

Vaccines Market Definition

The vaccines market consists of sales of vaccines by entities (organizations, sole traders and partnerships) that produce vaccines to prevent various diseases. Vaccines are biological preparations that stimulate the immune system and prepare it to fight future infections. The vaccine triggers the production of antibodies and a cellular immune response against the pathogen or its foreign proteins. Vaccines can be administered through different routes including intramuscular (IM), subcutaneous (SC), oral, and other routes. Vaccine doses are administered to both children (pediatric vaccines) and adults, based on the schedule set for each vaccine. For adults, the vaccines are recommended based on age, health condition, prior vaccinations, and other factors such as occupation or location, which increase the likelihood of exposure to the pathogen. The vaccines market is segmented into anti-infective vaccines; anti-cancer vaccines; and other-vaccines. Only goods and services traded between entities or sold to end consumers are included.

Book your 30 minutes free consultation with our research experts

Vaccines Market Size

The vaccines market reached a value of nearly $92,607.6 million in 2021, having grown at a compound annual growth rate (CAGR) of 8.1% since 2016. The market is expected to grow from $92,607.6 million in 2021 to $150,931.3 million in 2026 at a rate of 10.3%. The market is then expected to grow at a CAGR of 9.0% from 2026 and reach $232,624.0 million in 2031.

Growth in the historic period resulted from increased healthcare access, the coronavirus outbreak, continuous protection towards infectious diseases and increased awareness of immunization.

Going forward, increasing cases of invasive cervical cancer, strong late-stage pipeline and new vaccine approvals, increasing prevalence of infectious diseases among children, emergence of zoonotic diseases and vaccine resistant mutations will drive the growth. Factors that could hinder the growth of the vaccines market in the future include skilled workforce shortages and high cost of vaccines.

Vaccines Market Drivers

The key drivers of the vaccines market include:

Increasing Cases Of Invasive Cervical Cancer

Rise in cases of invasive cervical cancer is expected to propel the growth of the vaccines market during the forecast period. By using the HPV (Human papillomavirus) vaccine and regular cervical screenings, cervical cancer can be prevented. For example, according to the World Health Organization (WHO), a Switzerland based specialized agency of the United Nations responsible for international public health, the number of new cases of cervical cancer is expected to increase from 570,000 to 700,000 cases annually, between 2018 and 2030. Additionally, in 2022, according to The American Cancer Society, a US based voluntary health organization dedicated to eliminating cancer, estimates for cervical cancer in the United States, suggest about 14,100 new cases of invasive cervical cancer will be diagnosed in the year. About 4,280 women die from cervical cancer. Therefore, the increasing cases of invasive cervical cancer is expected to fuel the growth of the vaccines market during the forecast period.

Vaccines Market Restraints

The key restraints on the vaccines market include:

Skilled Workforce Shortages

Lack of suitably trained employees is expected to contribute to a shortage of labor across the professional services market for developing vaccines. Many companies are looking for candidates with advanced scientific skillsets leading to increasing competition for resources with these skillsets. This could impact the growth of the vaccine market which is heavily reliant on skilled manpower. For instance, according to a research by the National Association of Manufacturing, a US based advocacy group and Deloitte, a UK based professional services network, the number of vacancies for science, technology, engineering and math (STEM) jobs is expected to be around 3.5 million by 2025, but around 2 million of those jobs are likely to go unfilled due to shortage of people with the required skillset. Therefore, the skilled workforce shortages is likely to restrain the growth of the vaccines market during the forecast period.

Vaccines Market Trends

Major trends influencing the vaccines market include:

Synthetic Biology In Vaccine Development

Synthetic biology is being increasingly used by companies that are developing vaccines. Synthetic biology is a field of biology which involves engineering principles, whereby molecules and organisms are redesigned for useful purposes by engineering them to have new abilities. Synthetic biology tools significantly aid in drug discovery processes to help understand the molecular mechanisms of target diseases. Traditionally, vaccines are developed using the whole organism. Synthetic vaccines are based on complex carbohydrate-protein conjugates and can be easily stored at normal temperature without the need for refrigeration. Synthetic biology technologies such as DNA (Deoxyribonucleic acid) - and mRNA(Messenger Ribonucleic acid)-based vaccine technologies allow researchers to move rapidly from an organisms genomic sequence to a vaccine that directly encodes the organisms proteins, which can begin clinical trials. For example, in 2020, the US National Institute of Health, a US based primary agency of the responsible for biomedical and public health research, identified the importance of synthetic biology to speed up vaccine development. Additionally, in February 2020, the Bill & Melinda Gates Foundation, a US based private foundation, funded $60 million to COVID-19 research and vaccine developments based on synthetic biology.

Development Of Combination Vaccines

There has been an increasing demand for combination vaccines among infants and children. The development of combination vaccines for protection against multiple diseases was initiated by combining separate vaccines against tetanus, diphtheria, and pertussis into a single dose. The combination vaccines simplify childhood immunization schedules and reduce the number of injections while protecting against several serious diseases. Many companies have started developing combination vaccines as the demand increased. For instance, in November 2022, Pfizer Inc, a US based pharmaceutical and biotechnology corporation and BioNTech SE, a Germany based biotechnology company, announced the advancement of an mRNA-based combination vaccine candidate for influenza and COVID-19 to a Phase 1 trial with the aim to address two severe respiratory diseases with one vaccine. The first participant has been dosed in a Phase 1 trial evaluating the safety, tolerability, and immunogenicity of a nucleoside-modified RNA (Ribonucleic acid) (modRNA)-based combination vaccine approach. Further, in October 2020, Merck, a US based pharmaceutical company and Sanofi Pasteur, a France based pharmaceutical company, formed a U.S.-based joint-partnership vaccine company that developed, manufactured and marketed, VAXELIS, a combination vaccine for Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B.

Opportunities And Recommendations In The Vaccines Market

Opportunities –The top opportunities in the vaccines market segmented by type will arise in the anti-infective vaccines segment, which will gain $49,866.9 million of global annual sales by 2026. The top opportunities in segment by technology will arise in the conjugate vaccines segment, which will gain $26,610.1 million of global annual sales by 2026. The top opportunities in segment by route of administration will arise in the intramuscular (IM) segment, which will gain $30,201.7 million of global annual sales by 2026. The top opportunities in segment by valence will arise in the multivalent segment, which will gain $38,172.2 million of global annual sales by 2026. The top opportunities in segment by distribution channel will arise in the hospital pharmacies segment, which will gain $37,872.6 million of global annual sales by 2026. The vaccines market size will gain the most in the USA at $27,549.2 million.

Recommendations-To take advantage of the opportunities, The Business Research Company recommends the companies in the vaccines market to focus on development of combination vaccines, focus on research and development, focus on artificial intelligence, expand in emerging markets, continue to focus on developed markets, focus on partnerships and collaborations, provide competitively priced offerings, participate in trade shows and events, continue to use business-to-business (B2B) promotions and continue to target fast-growing end-users.

Vaccines Market Segmentation

The vaccines market is segmented by type, by technology, by route of administration, by valance, by distribution channel.
By Type –
The vaccines market is segmented by type into

a) Anti-Infective Vaccines
b) Anti-Cancer Vaccines
c) Other Types

The anti-infective vaccines market was the largest segment of the vaccines market segmented by type, accounting for 85.9% of the total in 2021. Going forward, the anti-cancer vaccines market is expected to be the fastest growing segment in the vaccines market segmented by type, at a CAGR of 10.7% during 2021-2026.
By Technology-
The vaccines market is segmented by technology into

a) Conjugate Vaccines
b) Inactivated And Subunit Vaccines
c) Live Attenuated Vaccines
d) Recombinant Vaccines
e) Toxoid Vaccines
f) Other Technologies

The conjugate vaccines market was the largest segment of the vaccines market segmented by technology accounting for 43.9% of the total in 2021. Going forward, the other technologies market is expected to be the fastest growing segment in the vaccines market segmented by technology, at a CAGR of 17.7% during 2021-2026.
By Route Of Administration-
The vaccines market is segmented by route of administration into

a) Intramuscular (IM)
b) Subcutaneous (SC)
c) Oral
d) Other Route of Administration

The intramuscular (IM) market was the largest segment of the vaccines market segmented by route of administration, accounting for 47.5% of the total in 2021. Going forward, the intramuscular (IM) market is expected to be the fastest growing segment in the vaccines market segmented by route of administration, at a CAGR of 11.0% during 2021-2026.
By Valance-
The vaccines market is segmented by valance into

a) Monovalent
b) Multivalent
d) Other Route of Administration

The multivalent market was the largest segment of the vaccines market segmented by valance, accounting for 61.5% of the total in 2021. Going forward, the multivalent market is expected to be the fastest growing segment in the vaccines market segmented by valance, at a CAGR of 10.8% during 2021-2026.
By Distribution Channel -
The vaccines market is segmented by distribution channel into

a) Hospital Pharmacies
b) Retail Pharmacies
c) Institutional Sales

The hospital pharmacies market was the largest segment of the vaccines market segmented by distribution channel, accounting for 30.5% of the total in 2021. Going forward, the institutional sales market is expected to be the fastest growing segment in the vaccines market segmented by distribution channel, at a CAGR of 12.7% during 2021-2026.
By Geography - The vaccines market is segmented by geography into

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA

• Brazil

• France
• Germany
• UK

• Russia

North America was the largest region in the vaccines market, accounting for 53.7% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the vaccines market will be Middle East, and, South America where growth will be at CAGRs of 14.6% and 13.0% respectively. These will be followed by Asia Pacific, and, Africa where the markets are expected to grow at CAGRs of 11.6% and 10.9% respectively.

Vaccines Market Competitive Landscape

Major Competitors are:

Pfizer Inc.

Merck & Co., Inc.

GlaxoSmithKline plc

Sanofi S.A.

AstraZeneca

Other Competitors Include:

CSL Limited

Serum Institute of India Pvt. Ltd.

Emergent BioSolutions Inc.

Daiichi Sankyo Company, Limited

Bavarian Nordic

Denteric Pvt Ltd

Hualan Biological Engineering Inc

Chongqing Zhifei

Beijing Tiantan Biological Products Co Ltd

BioKangtai

CanSino Biologics

Takeda Pharmaceutical Company

Mitsubishi Tanabe Pharma Corporation

Indian Immunologicals Limited

Panacea Biotec Ltd

Zydus Cadila

BIO-MED

Sinovac Biotech Ltd

Sun Pharmaceutical Industries Ltd

Sinopharm

Walvax biotechnology

Fosun Pharma

Valneva SE

BioFabri

ImevaX GmbH

Bayer

BioNTech

Boehringer Ingelheim

Novartis

MCM Vaccine Company

Seqirus

Roche

Johnson & Johnson

Connaught Laboratories Inc

Wyeth-Ayerst

Grifols

Moderna Inc

Verity Pharmaceuticals Canada Inc

Medicago Inc

Biodextris

IMV Inc

Virica Biotech

Fiocruz

GSK Brazil

Merck Brazil

Sinergium Biotech SA

Ataulfo de Paiva Foundation

Bio-Manguinhos–Institute of Technology on Immunobiologicals

Butantan Institute

Ezequiel Dias Foundation (FUNED)

National Administration of Laboratories and Institutes of Health (ANLIS)

Arabio

MIGAL Galilee Research Institute

Hayat-Vax

Phaax

VPS Health Care

Biovac Institute

1.Executive Summary

2.Table Of Contents

3.List Of Figures

4.List Of Tables

5.Report Structure

6.Introduction And Market Characteristics

6.1.General Market Definition

6.2.Summary

6.3.Vaccines Market Definition And Segmentations

6.4.Market Segmentation By Type

6.4.1.Anti-Infective Vaccines

6.4.2.Anti-Cancer Vaccines

6.4.3.Other Types

6.5.Market Segmentation By Technology

6.5.1.Conjugate Vaccines

6.5.2.Inactivated And Subunit Vaccines

6.5.3.Live Attenuated Vaccines

6.5.4.Recombinant Vaccines

6.5.5.Toxoid Vaccines

6.5.6.Other Technologies

6.6.Market Segmentation By Route Of Administration

6.6.1.Intramuscular (IM)

6.6.2.Subcutaneous (SC)

6.6.3.Oral

6.6.4.Other Route of Administration

6.7.Market Segmentation By Valance

6.7.1.Monovalent

6.7.2.Multivalent

6.8.Market Segmentation By Distribution Channel

6.8.1.Hospital Pharmacies

6.8.2.Retail Pharmacies

6.8.3.Institutional Sales

7.Major Market Trends

7.1.Synthetic Biology In Vaccine Development

7.2.Development Of Combination Vaccines

7.3.Robust Research And Development

7.4.Increasing Demand For Conjugate Vaccines

7.5.Artificial Intelligence In Vaccine Development

7.6.mRNA Vaccines

7.7.Cancer Vaccines

7.8.Increasing Acquisitions And Partnerships

8.Global Market Size And Growth

8.1.Market Size

8.2.Historic Market Growth, 2016 – 2021, Value ($ Million)

8.2.1.Market Drivers 2016 – 2021

8.2.2.Market Restraints 2016 – 2021

8.3.Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

8.3.1.Market Drivers 2021 – 2026

8.3.2.Market Restraints 2021 – 2026

9.Global Vaccines Market Segmentation

9.1.Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

9.2.Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

9.3.Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

9.4.Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

9.5.Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

10.Vaccines Market, Regional and Country Analysis

10.1.Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

10.2.Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.Asia-Pacific Market

11.1.Summary

11.2.Market Overview

11.2.1.Region Information

11.2.2.Market Information

11.2.3.Background Information

11.2.4.Government Initiatives

11.2.5.Regulations

11.2.6.Regulatory Bodies

11.2.7.Major Associations

11.2.8.Taxes Levied

11.2.9.Corporate Tax Structure

11.2.10.Investments

11.2.11.Major Companies

11.3.Asia-Pacific Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

11.4.Asia-Pacific Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

11.5.Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.6.Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.7.Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.8.Asia-Pacific Vaccines Market: Country Analysis

11.9.China Market

11.10.Summary

11.11.Market Overview

11.11.1.Country Information

11.11.2.Market Information

11.11.3.Background Information

11.11.4.Government Initiatives

11.11.5.Regulations

11.11.6.Regulatory Bodies

11.11.7.Major Associations

11.11.8.Taxes Levied

11.11.9.Corporate Tax Structure

11.11.10.Investments

11.11.11.Major Companies

11.12.China Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

11.13.China Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

11.14.China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.15.China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.16.China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.17.India Market

11.18.India Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

11.19.India Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

11.20.India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.21.India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.22.India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.23.Japan Market

11.24.Japan Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

11.25. Japan Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

11.26. Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.27. Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.28. Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.29. Australia Market

11.30. Australia Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

11.31. Australia Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

11.32. Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.33. Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.34. Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.35. Indonesia Market

11.36. Indonesia Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

11.37. Indonesia Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

11.38. Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.39. Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.40. Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.41. South Korea Market

11.42. South Korea Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

11.43. South Korea Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

11.44. South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.45. South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

11.46. South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12. Western Europe Market

12.1. Summary

12.2. Market Overview

12.2.1. Region Information

12.2.2. Market Information

12.2.3. Background Information

12.2.4. Government Initiatives

12.2.5. Regulations

12.2.6. Regulatory Bodies

12.2.7. Major Associations

12.2.8. Taxes Levied

12.2.9. Corporate Tax Structure

12.2.10. Investments

12.2.11. Major Companies

12.3. Western Europe Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

12.4. Western Europe Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

12.5. Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.6. Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.7. Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.8. Western Europe Vaccines Market: Country Analysis

12.9. UK Market

12.10. UK Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

12.11. UK Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

12.12. UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.13. UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.14. UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.15. Germany Market

12.16. Germany Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

12.17. Germany Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

12.18. Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.19. Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.20. Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.21. France Market

12.22. France Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

12.23. France Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

12.24. France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.25. France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

12.26. France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

13. Eastern Europe Market

13.1. Summary

13.2. Market Overview

13.2.1. Region Information

13.2.2. Market Information

13.2.3. Background Information

13.2.4. Government Initiatives

13.2.5. Regulations

13.2.6. Regulatory Bodies

13.2.7. Major Associations

13.2.8. Taxes Levied

13.2.9. Corporate Tax Structure

13.2.10. Investments

13.2.11. Major Companies

13.3. Eastern Europe Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

13.4. Eastern Europe Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

13.5. Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

13.6. Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

13.7. Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

13.8. Eastern Europe Vaccines Market: Country Analysis

13.9. Russia Market

13.10. Russia Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

13.11. Russia Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

13.12. Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

13.13. Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

13.14. Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

14. North America Market

14.1. Summary

14.2. Market Overview

14.2.1. Region Information

14.2.2. Market Information

14.2.3. Background Information

14.2.4. Government Initiatives

14.2.5. Regulations

14.2.6. Regulatory Bodies

14.2.7. Major Associations

14.2.8. Taxes Levied

14.2.9. Corporate Tax Structure

14.2.10. Investments

14.2.11. Major Companies

14.3. North America Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

14.4. North America Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

14.5. North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

14.6. North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

14.7. North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

14.8. North America Vaccines Market: Country Analysis

14.9. USA Market

14.10. Summary

14.11. Market Overview

14.11.1. Country Information

14.11.2. Market Information

14.11.3. Background Information

14.11.4. Government Initiatives

14.11.5. Regulations

14.11.6. Regulatory Bodies

14.11.7. Major Associations

14.11.8. Taxes Levied

14.11.9. Corporate Tax Structure

14.11.10. Investments

14.11.11. Major Companies

14.12. USA Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

14.13. USA Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

14.14. USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

14.15. USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

14.16. USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

15. South America Market

15.1. Summary

15.2. Market Overview

15.2.1. Region Information

15.2.2. Market Information

15.2.3. Background Information

15.2.4. Government Initiatives

15.2.5. Regulations

15.2.6. Regulatory Bodies

15.2.7. Major Associations

15.2.8. Taxes Levied

15.2.9. Corporate Tax Structure

15.2.10. Investments

15.2.11. Major Companies

15.3. South America Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

15.4. South America Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

15.5. South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

15.6. South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

15.7. South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

15.8. South America Vaccines Market: Country Analysis

15.9. Brazil Market

15.10. Brazil Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

15.11. Brazil Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

15.12. Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

15.13. Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

15.14. Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

16. Middle East Market

16.1. Summary

16.2. Market Overview

16.2.1. Region Information

16.2.2. Market Information

16.2.3. Background Information

16.2.4. Government Initiatives

16.2.5. Regulations

16.2.6. Regulatory Bodies

16.2.7. Major Associations

16.2.8. Taxes Levied

16.2.9. Corporate Tax Structure

16.2.10. Investments

16.2.11. Major Companies

16.3. Middle East Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

16.4. Middle East Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

16.5. Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

16.6. Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

16.7. Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

17. Africa Market

17.1. Summary

17.2. Market Overview

17.2.1. Region Information

17.2.2. Market Information

17.2.3. Background Information

17.2.4. Government Initiatives

17.2.5. Regulations

17.2.6. Regulatory Bodies

17.2.7. Major Associations

17.2.8. Taxes Levied

17.2.9. Corporate Tax Structure

17.2.10. Investments

17.2.11. Major Companies

17.3. Africa Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)

17.4. Africa Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)

17.5. Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

17.6. Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

17.7. Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)

18. Competitive Landscape and Company Profiles

19. Company Profiles

19.1. Pfizer Inc

19.1.1. Company Overview

19.1.2. Products And Services

19.1.3. Business Strategy

19.1.4. Financial Overview

19.2. Merck & Co., Inc

19.2.1. Company Overview

19.2.2. Products And Services

19.2.3. Business Strategy

19.2.4. Financial Overview

19.3. GlaxoSmithKline plc

19.3.1. Company Overview

19.3.2. Products And Services

19.3.3. Business Strategy

19.3.4. Financial Overview

19.4. Sanofi S.A

19.4.1. Company Overview

19.4.2. Products And Services

19.4.3. Business Strategy

19.4.4. Financial Overview

19.5. AstraZeneca plc

19.5.1. Company Overview

19.5.2. Products And Services

19.5.3. Business Strategy

19.5.4. Financial Overview

20. Pipeline Analysis

21. Key Mergers And Acquisitions

21.1. GSK plc Acquired Affinivax Inc

21.2. Ceva Santé Animale Acquired Artemis Technologies Inc.

21.3. Pfizer Inc. Acquired ReViral Ltd.

21.4. NEC OncoImmunity AS Acquired Vaximm AG’s Neoantigen Vaccine Development Assets.

21.5. Sanofi S.A. To Acquire Origimm Biotechnology GmbH

21.6. Vaccitech plc Acquired Avidea Technologies, Inc.

21.7. Shanghai Fosun Pharmaceutical Co., Ltd. Acquired Chengdu Antejin Biotech Co. Ltd.

21.8. Sanofi S.A. Acquired Translate Bio, Inc.

21.9. Thermo Fisher Scientific Inc. Acquired Viral Vector Manufacturing Business from Novasep SAS

21.10. Merck KGaA’s Life Sciences Company MilliporeSigma Acquired AmpTec

21.11. Sanofi S.A. Acquired Kymab Ltd

21.12. BioNTech SE Acquired GMP Certified Manufacturing Site of Novartis AG

21.13. GlaxoSmithKline plc Acquired 10% Stake In CureVac For $163.67 million

21.14. Merck & Co., Inc. Acquired Themis Bioscience GmbH

21.15. Novavax, Inc. Acquired Praha Vaccines For $167 million

21.16. Bavarian Nordic A/S Acquired Global Rights for Two Vaccines from GSK For $940.07 Million

21.17. Bharat Biotech International Limited Acquired Chiron Behring Vaccines from GlaxoSmithKline

22. Global Vaccines Market Opportunities And Strategies

22.1. Global Vaccines Market In 2026 – Countries Offering Most New Opportunities

22.2. Global Vaccines Market In 2026 – Segments Offering Most New Opportunities

22.3. Global Vaccines Market In 2026 – Growth Strategies

22.3.1. Market Trend Based Strategies

22.3.2. Competitor Strategies

23. Vaccines Market, Conclusions And Recommendations

23.1. Conclusions

23.2.Recommendations

23.2.1.Product

23.2.2.Place

23.2.3.Price

23.2.4.Promotion

23.2.5.People

24.Appendix

24.1.Market Data Sources

24.2.Research Methodology

24.3.Currencies

24.4.The Business Research Company

24.5.Copyright and Disclaimer

List Of Tables

Table 1: Global Vaccines Market, Historic, 2016 – 2021, $ Million

Table 2: Global Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 3: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 4: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 5: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 6: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 7: Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 8: Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 9: Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 10: Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 11: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 12: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 13: Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %

Table 14: Global Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 15: Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %

Table 16: Global Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 17: Asia-Pacific GDP Per Capita, By Country, 2016-2021, $

Table 18: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands

Table 19: Asia-Pacific Public Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 20: Asia-Pacific Private Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 21: Asia-Pacific Vaccines Market, Historic, 2016 – 2021, $ Million

Table 22: Asia-Pacific Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 23: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 24: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 25: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 26: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 27: Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 28: Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 29: China GDP Per Capita, 2016-2021, $

Table 30: China Population By Age Group, 2016-2026, Thousands

Table 31: China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion

Table 32: China Vaccines Market, Historic, 2016 – 2021, $ Million

Table 33: China Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 34: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 35: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 36: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 37: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 38: China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 39: China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 40: India Vaccines Market, Historic, 2016 – 2021, $ Million

Table 41: India Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 42: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 43: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 44: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 45: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 46: India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 47: India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 48: Japan Vaccines Market, Historic, 2016 – 2021, $ Million

Table 49: Japan Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 50: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 51: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 52: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 53: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 54: Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 55: Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 56: Australia Vaccines Market, Historic, 2016 – 2021, $ Million

Table 57: Australia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 58: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 59: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 60: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 61: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 62: Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 63: Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 64: Indonesia Vaccines Market, Historic, 2016 – 2021, $ Million

Table 65: Indonesia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 66: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 67: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 68: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 69: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 70: Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 71: Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 72: South Korea Vaccines Market, Historic, 2016 – 2021, $ Million

Table 73: South Korea Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 74: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 75: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 76: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 77: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 78: South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 79: South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 80: Western Europe GDP Per Capita, By Country, 2016-2021, $

Table 81: Western Europe Population By Age Group, By Country, 2016-2026, Thousands

Table 82: Western Europe Public Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 83: Western Europe Private Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 84: Western Europe Vaccines Market, Historic, 2016 – 2021, $ Million

Table 85: Western Europe Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 86: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 87: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 88: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 89: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 90: Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 91: Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 92: UK Vaccines Market, Historic, 2016 – 2021, $ Million

Table 93: UK Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 94: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 95: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 96: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 97: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 98: UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 99: UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 100: Germany Vaccines Market, Historic, 2016 – 2021, $ Million

Table 101: Germany Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 102: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 103: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 104: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 105: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 106: Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 107: Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 108: France Vaccines Market, Historic, 2016 – 2021, $ Million

Table 109: France Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 110: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 111: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 112: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 113: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 114: France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 115: France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 116: Eastern Europe GDP Per Capita, By Country, 2016-2021, $

Table 117: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands

Table 118: Eastern Europe Public Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 119: Eastern Europe Private Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 120: Eastern Europe Vaccines Market, Historic, 2016 – 2021, $ Million

Table 121: Eastern Europe Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 122: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 123: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 124: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 125: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 126: Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 127: Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 128: Russia Vaccines Market, Historic, 2016 – 2021, $ Million

Table 129: Russia Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 130: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 131: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 132: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 133: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 134: Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 135: Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 136: North America GDP Per Capita, By Country, 2016-2021, $

Table 137: North America Population By Age Group, By Country, 2016-2026, Thousands

Table 138: North America Public Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 139: North America Private Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 140: North America Vaccines Market, Historic, 2016 – 2021, $ Million

Table 141: North America Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 142: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 143: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 144: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 145: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 146: North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 147: North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 148: USA GDP Per Capita, 2016-2021, $

Table 149: USA Population By Age Group, 2016-2026, Thousands

Table 150: USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion

Table 151: USA Vaccines Market, Historic, 2016 – 2021, $ Million

Table 152: USA Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 153: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 154: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 155: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 156: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 157: USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 158: USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 159: South America GDP Per Capita, By Country, 2016-2021, $

Table 160: South America Population By Age Group, By Country, 2016-2026, Thousands

Table 161: South America Public Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 162: South America Private Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 163: South America Vaccines Market, Historic, 2016 – 2021, $ Million

Table 164: South America Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 165: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 166: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 167: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 168: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 169: South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 170: South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 171: Brazil Vaccines Market, Historic, 2016 – 2021, $ Million

Table 172: Brazil Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 173: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 174: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 175: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 176: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 177: Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 178: Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 179: Middle East GDP Per Capita, By Country, 2016-2021, $

Table 180: Middle East Population By Age Group, By Country, 2016-2026, Thousands

Table 181: Middle East Public Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 182: Middle East Private Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 183: Middle East Vaccines Market, Historic, 2016 – 2021, $ Million

Table 184: Middle East Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 185: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 186: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 187: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 188: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 189: Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 190: Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 191: Africa GDP Per Capita, By Country, 2016-2021, $

Table 192: Africa Population By Age Group, By Country, 2016-2026, Thousands

Table 193: Africa Public Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 194: Africa Private Healthcare Expenditure, By Country, 2015-2020, $ Billion

Table 195: Africa Vaccines Market, Historic, 2016 – 2021, $ Million

Table 196: Africa Vaccines Market, Forecast, 2021 – 2026, 2031F, $ Million

Table 197: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 198: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 199: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 200: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 201: Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Table 202: Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million

Table 203: Vaccines Market, Key Competitor Estimated Market Shares, 2021, Percentage (%)

Table 204: Pfizer – Financial Performance, 2017– 2021, $ Billion

Table 205: Merck & Co – Financial Performance, 2017– 2021, $ Billion

Table 206: GlaxoSmithKline – Financial Performance, 2017 - 2021, $ Billion

Table 207: Sanofi – Financial Performance, 2017– 2021, $ Billion

Table 208: AstraZeneca – Financial Performance, 2017– 2021, $ Billion

Table 209: Global Vaccine Market, Product Pipeline Analysis

Table 210: Global Vaccines Market Size Gain ($ Million), 2021 – 2026, By Country

Table 211: Global Vaccines Market Size Gain ($ Million), Segmentation By Type, 2021 – 2026

Table 212: Global Vaccines Market Size Gain ($ Million), Segmentation By Technology, 2021 – 2026

Table 213: Global Vaccines Market Size Gain ($ Million), Segmentation By Route Of Administration, 2021 – 2026

Table 214: Global Vaccines Market Size Gain ($ Million), Segmentation By Valence, 2021 – 2026

Table 215: Global Vaccines Market Size Gain ($ Million), Segmentation By Distribution Channel, 2021 – 2026

Table 216: Vaccines Market Data Sources

List Of Figures

Figure 1: Global Vaccines Market Segmentation By Type

Figure 2: Global Vaccines Market Segmentation By Technology

Figure 3: Global Vaccines Market Segmentation By Route of Administration

Figure 4: Global Vaccines Market Segmentation By Valance

Figure 5: Global Vaccines Market Segmentation By Distribution Channel

Figure 6: Global Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 7: Global Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 8: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 9: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 10: Global Vaccines Market, Segmentation By Route of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 11: Global Vaccines Market, Segmentation By Valance, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 12: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 13: Global Vaccines Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 14: Global Vaccines Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 15: Asia-Pacific Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 16: Asia-Pacific Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 17: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 18: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 19: China Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 20: China Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 21: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 22: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 23: India Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 24: India Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 25: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 26: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 27: Japan Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 28: Japan Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 29: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 30: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 31: Australia Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 32: Australia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 33: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 34: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 35: Indonesia Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 36: Indonesia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 37: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 38: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 39: South Korea Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 40: South Korea Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 41: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 42: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 43: Western Europe Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 44: Western Europe Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 45: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 46: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 47: UK Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 48: UK Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 49: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 50: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 51: Germany Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 52: Germany Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 53: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 54: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 55: France Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 56: France Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 57: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 58: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 59: Eastern Europe Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 60: Eastern Europe Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 61: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 62: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 63: Russia Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 64: Russia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 65: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 66: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 67: North America Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 68: North America Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 69: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 70: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 71: USA Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 72: USA Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 73: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 74: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 75: South America Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 76: South America Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 77: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 78: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 79: Brazil Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 80: Brazil Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 81: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 82: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 83: Middle East Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 84: Middle East Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 85: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 86: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 87: Africa Vaccines Market, Historic, 2015 – 2020, $ Million

Figure 88: Africa Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million

Figure 89: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 90: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %

Figure 91: Global Vaccines Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

Figure 92: GlaxoSmithKline plc – Financial Performance, 2016 – 2020, $ Billion

Figure 93: Merck & Co., Inc. – Financial Performance, 2016 – 2020, $ Billion

Figure 94: Sanofi S.A. – Financial Performance, 2016 – 2020, $ Billion

Figure 95: Pfizer Inc. – Financial Performance, 2016 – 2020, $ Billion

Figure 96: CSL Limited – Financial Performance, 2016 – 2020, $ Billion

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034

Companion Animal Veterinary Vaccines Global Market Report 2025 – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DTP Vaccines Global Market Report 2025 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Drugs for Immunotherapy Global Market Report 2025 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Liposomal Drug Delivery Devices Global Market Report 2025 – By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types), By Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Vaccines Global Market Report 2025 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Drugs And Biologics Logistics Market 2021 - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030

View Report

Vaccines Global Market Opportunities And Strategies To 2031

Vaccines Global Market Opportunities And Strategies To 2031

Market Insights

Related Reports

Vaccines Market Definition

Vaccines Market Size

Vaccines Market Drivers

Vaccines Market Restraints

Vaccines Market Trends

Opportunities And Recommendations In The Vaccines Market

Vaccines Market Segmentation

Vaccines Market Competitive Landscape

Major Competitors are:

Other Competitors Include:

Table Of Contents

List Of Tables

List Of Figures

Top Growth Trends in the Spine Biologics Market: Insights into Market Size and Opportunities for 2025-2034

Subcutaneous Immunoglobulin (SCIG) Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead

Tacrolimus Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Tetanus Toxoid Vaccine Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034

Topical Wound Agents Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

Understanding Key Drivers and Growth Opportunities in the Tylosin Market: Trends and Market Size Insights

Urology Supplements Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

DTP Vaccines Global Market Report 2025 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2025-2034

Frequently Asked Questions